ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,744.17
      -0.02%
      US Tech 100
      19,488.40
      -0.46%
      Dow Jones
      42,413.24
      0.56%
      Brent Oil
      71.525
      0.81%
      Bitcoin
      66,236.00
      1.62%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT

      6. Sanofi (1SAN) Quote

      Sanofi

      Sanofi (1SAN)

      BIT
      103.34
      1.34
      (1.31%)
      Closed September 27 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      103.34
      Bid
      101.56
      Ask
      104.10
      Volume
      436
      101.66 Day's Range 103.34
      80.75 52 Week Range 107.96
      Market Cap
      129.448B
      Previous Close
      102.00
      Open
      101.74
      Last Trade
      10
      @
      103.34
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,041
      Shares Outstanding
      1,252,640,466
      Dividend Yield
      3.64%
      PE Ratio
      23.89
      Earnings Per Share (EPS)
      4.31
      Revenue
      43.07B
      Net Profit
      5.4B

      About Sanofi

      Sector
      Health & Allied Services,nec
      Industry
      Pharmaceutical Preparations
      Website
      www.sanofi.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1994
      Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 102.00 €. Over the last year, Sanofi shares have traded in a share price range of 80.75 € to 107.96 €.

      Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 127.77 € billion. Sanofi has a price to earnings ratio (PE ratio) of 23.89.

      Ask ADVFN Intelligence (AI)

      1SAN Latest News

      More News

      Communiqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO

      Communiqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO     Dupixent est le premier médicament biologique approuvé aux États-Unis...

      3 hours ago
      UK Regulatory

      Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD

      Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD   Dupixent approved in the US as the first-ever biologic medicine for patients with...

      3 hours ago
      UK Regulatory

      Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO

      Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la...

      6 hours ago
      UK Regulatory

      Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD

      Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval...

      6 hours ago
      UK Regulatory

      Communiqué de presse : Mise en ligne du document «Q3 2024 Aide mémoire »

      Communiqué de presse : Mise en ligne du document «Q3 2024 Aide mémoire » Mise en ligne du document «Q3 2024 Aide mémoire » Paris, France, le 26 Septembre 2024. Sanofi annonce la mise en ligne sur...

      September 26 2024
      UK Regulatory

      Press Release: Availability of the Q3 2024 Aide mémoire

      Press Release: Availability of the Q3 2024 Aide mémoire Availability of the Q3 2024 Aide mémoire Paris, France – September 26, 2024. Sanofi announced today that its Q3 2024 Aide mémoire is...

      September 26 2024
      UK Regulatory

      Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant

      Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for...

      September 20 2024
      UK Regulatory

      Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué (...)

      Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement...

      September 20 2024
      UK Regulatory

      Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

      Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Dupixent recommended for EU approval by the CHMP to treat...

      September 20 2024
      UK Regulatory

      Communiqué de presse : Le CHMP recommande l’approbation du Dupixent dans l’UE pour le traitement de l’œsophagite à éosinophiles de l’enfant à partir de 12 mois  

      Communiqué de presse : Le CHMP recommande l’approbation du Dupixent dans l’UE pour le traitement de l’œsophagite à éosinophiles de l’enfant à partir de 12 mois   Le CHMP recommande l’approbation...

      September 20 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.18-1.12897053196104.52104.6293418102.8995122DE
      41.561.53271762625101.78106.193789104.15402092DE
      1212.3413.560439560491107.9690.86104197.77303457DE
      2612.113.261727312691.24107.9685.1495093.89738083DE
      521.221.1946729338102.12107.9680.7590691.08385124DE
      15621.0525.580264916882.29107.9676.36103090.94909871DE
      26018.4821.77704454484.86107.9668154687.48081907DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WCOP25Copernico Sim S.p.a
      0.46 €
      (43.84%)
      		5.03k
      MONMonrif Spa
      0.0498 €
      (23.88%)
      		10.65M
      WNUS26Nusco Spa
      0.2098 €
      (23.48%)
      		12.75k
      GGGiglio Group
      0.514 €
      (20.09%)
      		608.09k
      TMPTPM Group SpA
      1.58 €
      (17.04%)
      		29.2k
      WTWL24TraWell Co SA
      0.1999 €
      (-38.68%)
      		2.58k
      WGML25GM Leather spa
      0.011 €
      (-29.03%)
      		47k
      ENYEnergy Spa
      0.94 €
      (-15.70%)
      		357.5k
      AEDESAedes SpA
      0.20 €
      (-10.71%)
      		874.72k
      WTMP25TPM Group SpA
      0.0009 €
      (-10.00%)
      		3k
      TITTelecom Italia SpA
      0.2476 €
      (1.10%)
      		107.09M
      ISPIntesa Sanpaolo Spa
      3.8675 €
      (-0.22%)
      		63.13M
      SPMSaipem Spa
      1.948 €
      (1.46%)
      		30.71M
      EPHEPH SpA
      0.0002 €
      (0.00%)
      		21.73M
      ENELEnel Spa
      7.199 €
      (0.60%)
      		21.65M

      Discussion

      View Full Feed
      MNKD_RISE MNKD_RISE 3 minutes ago
      style="caret-color: rgb(49, 49, 49); color: rgba(49, 49, 49, 1); font-family: -apple-system, "Helvetica Neue"; word-spacing: 1px"No it simply means that the Company's local counsel wants to make sure the Magistrate understands how ridiculous is the defendant's motion to release Browning Holcombe and
      The Man With No Name The Man With No Name 3 minutes ago
      Reality will one day hit you like a sledgehammer. Until then, you will keep peddling your nonsense.
      FNMA
      Turbomunkey Turbomunkey 4 minutes ago
      Oh wow
      RXMD
      TradeForProfits TradeForProfits 4 minutes ago
      $GPOX #NYSE interview includes: recent expansion into Austin, San Antonio, and Houston. Stage set for over 1,000 store locations? Read more here: https://finance.yahoo.com/news/gpoplus-selected-interview-floor-nyse-110000208.html
      GPOX
      familyof5 familyof5 4 minutes ago
      Awesome!
      RDGL
      The Night Stalker The Night Stalker 4 minutes ago
      past due for update
      BRNE
      PennyMillions852 PennyMillions852 4 minutes ago
      Not hating at all, just asking what is it ready for? It’s been ready to move up yet. We keep getting screwed.
      IGPK
      Vettelover98 Vettelover98 4 minutes ago
      There’s been speculation a buyout would happen… which would be nice but they’ve already turned down deals before.. so idk
      SOUN
      Poo28 Poo28 5 minutes ago
      Reggie James Joins Steve Preda on the Management Blueprint Podcast - Digital Clarity

      Source: Digital Clarity

      https://www.digital-clarity.com/blog/reggie-james-joins-steve-preda-on-the-management-blueprint-podcast-insights-for-b2b-tech-leaders/

      $DBMM
      DBMM
      PokerStar PokerStar 5 minutes ago
      Looking stronger now. About to see bids above .60 cents. We could go green at some point today...


      PokerStar
      RNAZ
      jgsnys jgsnys 5 minutes ago
      Aw c'mon Jammie!. . . "Too much up and down." . . . That does not sound like you. . . . Which do you like more, the "Up" or the "Down"?
      I bet the real reason is you have a high-level conference with "Duffman".
      ELTP
      JoshuaCox JoshuaCox 5 minutes ago
      RAD’s 32-unit order adds strength to AITX stock performance – more ARR growth expected!
      RNAZ
      JoshuaCox JoshuaCox 5 minutes ago
      AITX stock surges with RAD’s growing sales pipeline and major expansion orders on the horizon!
      Newton67_ Newton67_ 5 minutes ago
      Trading z. I have been here 4+ years myself from the beginning !! We are so close to getting the truth of this situation… all I am saying is all of us need to be careful and not make a wrong move until we hear more… for me I am not selling my shares of ENZC .. if people want to invest in Cha
      ENZC
      AlwaysRed AlwaysRed 5 minutes ago
      Gonna get worse.
      VNUE
      QuicKtip QuicKtip 5 minutes ago
      $XXII announced a new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. https://finance.yahoo.com/news/22nd-century-announces-branded-products-120000365.html
      XXII
      JoshuaCox JoshuaCox 5 minutes ago
      New orders boost AITX stock as RAD’s AI-powered security tech revolutionizes the industry.
      IGPK
      QuicKtip QuicKtip 5 minutes ago
      $XXII announced a new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. https://finance.yahoo.com/news/22nd-century-announces-branded-products-120000365.html
      XXII
      Debunkinator Debunkinator 5 minutes ago
      100 share paint job on 5's--LOL Keep trying $$$$$$$$ 🚂🌝
      ASII
      The Man With No Name The Man With No Name 5 minutes ago
      Profitable but statutorily insolvent, hence why they are in Conservatorship.
      FNMA
      jammy32 jammy32 5 minutes ago
      Ok. Then I won’t get out. Thanks for sharing
      ELTP
      peanutz peanutz 5 minutes ago
      I would fall over 😆
      NBRI
      JoshuaCox JoshuaCox 5 minutes ago
      AITX stock poised for further growth with RAD’s innovative security solutions attracting more clients.
      NBRI

      Your Recent History

      BIT
      1SAN
      Sanofi
      Delayed Upgrade Clock